BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/23/2024 9:31:45 AM | Browse: 182 | Download: 591
Publication Name World Journal of Hepatology
Manuscript ID 90039
Country China
Received
2023-11-21 09:21
Peer-Review Started
2023-11-21 09:23
To Make the First Decision
Return for Revision
2023-12-05 17:54
Revised
2023-12-18 03:44
Second Decision
2024-01-09 02:52
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief
2024-01-09 05:44
Articles in Press
2024-01-09 05:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2024-01-18 07:19
Publish the Manuscript Online
2024-01-23 09:31
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Retrospective Cohort Study
Article Title Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study
Manuscript Source Unsolicited Manuscript
All Author List Xue-Mei Tao, Ming-Hui Zeng, You-Fei Zhao, Jia-Xin Han, Yu-Qiang Mi and Liang Xu
ORCID
Author(s) ORCID Number
Xue-Mei Tao http://orcid.org/0000-0003-1245-0343
Yu-Qiang Mi http://orcid.org/0000-0001-7809-2679
Liang Xu http://orcid.org/0000-0001-5441-1217
Funding Agency and Grant Number
Funding Agency Grant Number
Chinese Foundation for Hepatitis Prevention and Control—Tian Qing Hepatitis Research Fund No. TQGB20210175
Tianjin Key Medical Discipline (Specialty) Construction Project TJYXZDXK-059B
Tianjin Health Science and Technology Project key discipline special TJWJ2022XK034
Research project of Chinese traditional medicine and Chinese traditional medicine combined with Western medicine of Tianjin municipal health and Family Planning Commission 2021022
Corresponding Author Liang Xu, MA, Attending Doctor, Clinical School of the Second People’s Hospital, Tianjin Medical University, No. 75 Sudi Road, Nankai District, Tianjin 300192, China. xuyangliang2004@sina.com
Key Words Direct-acting antivirals; Sustained viral response; Cirrhosis; Hepatocellular carcinoma; Risk factor
Core Tip We evaluated the effect of direct-acting antivirals (DAAs) on the development of hepatocellular carcinoma (HCC) in patients with hepatitis C virus (HCV)-associated cirrhosis during long-term follow-up. We performed propensity score matching, Kaplan-Meier curve and Log-Rank test, the incidence and cumulative incidence of HCC in DAAs treatment group (n = 236) and non-antiviral treatment group (n = 118) were retrospectively evaluated, and the risk factors for HCC were evaluated by Cox regression. We found that DAAs treatment of HCV-associated cirrhosis failed to reduce the incidence of HCC over 48 mo. Age and liver stiffness measurement were risk factors for developing HCC in all patients (n = 427), and DAAs treatment showed no protective effect.
Publish Date 2024-01-23 09:31
Citation Tao XM, Zeng MH, Zhao YF, Han JX, Mi YQ, Xu L. Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study. World J Hepatol 2024; 16(1): 41-53
URL https://www.wjgnet.com/1948-5182/full/v16/i1/41.htm
DOI https://dx.doi.org/10.4254/wjh.v16.i1.41
Full Article (PDF) WJH-16-41-with-cover.pdf
Full Article (Word) WJH-16-41.docx
STROBE Statement 90039-STROBE statement.pdf
Manuscript File 90039_Auto_Edited-LJH-YJP.docx
Answering Reviewers 90039-Answering reviewers.pdf
Audio Core Tip 90039-Audio core tip.aac
Biostatistics Review Certificate 90039-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 90039-Conflict-of-interest statement.pdf
Copyright License Agreement 90039-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s) 90039-Grant application form(s).pdf
Signed Informed Consent Form(s) or Document(s) 90039-Informed consent statement.pdf
Institutional Review Board Approval Form or Document 90039-Institutional review board statement.pdf
Peer-review Report 90039-Peer-review(s).pdf
Scientific Misconduct Check 90039-Bing-Liu JH-2.png
Scientific Misconduct Check 90039-CrossCheck.png
Scientific Editor Work List 90039-Scientific editor work list.pdf
CrossCheck Report 90039-CrossCheck report.pdf